Display options
Cite
Manova M, Petkova E, Yordanova S, et al. Budget Impact Analysis of Adding Dapaglifozin To The Therapy of Diabetes Mellitus Type 2 In Bulgaria. Value Health. 2014;17(7):A337doi: 10.1016/j.jval.2014.08.656.
Manova, M., Petkova, E., Yordanova, S., Petkova, V., & Petrova, G. (2014). Budget Impact Analysis of Adding Dapaglifozin To The Therapy of Diabetes Mellitus Type 2 In Bulgaria. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A337. https://doi.org/10.1016/j.jval.2014.08.656
Manova, M, et al. "Budget Impact Analysis of Adding Dapaglifozin To The Therapy of Diabetes Mellitus Type 2 In Bulgaria." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A337. doi: https://doi.org/10.1016/j.jval.2014.08.656
Manova M, Petkova E, Yordanova S, Petkova V, Petrova G. Budget Impact Analysis of Adding Dapaglifozin To The Therapy of Diabetes Mellitus Type 2 In Bulgaria. Value Health. 2014 Nov;17(7):A337. doi: 10.1016/j.jval.2014.08.656. Epub 2014 Oct 26. PMID: 27200607.
Copy Download .nbib Format: NLM
Share it on

Value Health. 2014 Nov;17(7):A337. doi: 10.1016/j.jval.2014.08.656. Epub 2014 Oct 26.

Budget Impact Analysis of Adding Dapaglifozin To The Therapy of Diabetes Mellitus Type 2 In Bulgaria.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

M Manova, E Petkova, S Yordanova, V Petkova, G Petrova

Affiliations

  1. Medical University of Sofia, Faculty of Pharmacy, Sofia, Bulgaria.
  2. Medical University Sofia, Faculty of Pharmacy, Sofia, Bulgaria.

PMID: 27200607 DOI: 10.1016/j.jval.2014.08.656

[No abstract available.]

Publication Types